inter-batch variability? [Regulatives / Guidelines]

posted by Pavidus – 2010-08-04 13:57 (5174 d 21:29 ago) – Posting: # 5714
Views: 16,637

Dear Dr_Dan & all,

Allow me one general remark:
IMHO BE studies are definitely not suitable to assess inter-batch variability of any product.

I am not saying, that this remark will "save" your product .... discussion with 'assessors' is always difficult... :-(

(btw. nice figures for a highly-variable drug)

Kind regards, P.

Complete thread:

UA Flag
Activity
 Admin contact
23,240 posts in 4,884 threads, 1,653 registered users;
69 visitors (1 registered, 68 guests [including 11 identified bots]).
Forum time: 11:27 CEST (Europe/Vienna)

[The] impatience with ambiguity can be criticized in the phrase:
absence of evidence is not evidence of absence.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5